HIGH GRADE GLIOMA (III OR IV)
Clinical trials for HIGH GRADE GLIOMA (III OR IV) explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE GLIOMA (III OR IV) trials appear
Sign up with your email to follow new studies for HIGH GRADE GLIOMA (III OR IV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets tough brain cancers in early trial
Disease control Not yet recruitingThis early-stage study tests a new drug called FZ-AD005 in about 40 people with aggressive brain tumors (high-grade glioma) that have come back or not responded to treatment. The drug is designed to deliver a cancer-killing agent directly to tumor cells. The main goals are to fin…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Promising targeted therapy takes on deadliest childhood brain cancers
Disease control Not yet recruitingThis study tests a drug called tovorafenib in children and young adults (ages 1 to 39) newly diagnosed with aggressive brain tumors (high-grade glioma or DIPG) that have specific genetic changes. The goal is to see if the drug can help patients live longer by targeting those gene…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 08:33 UTC